CN1144117A - Yigan medical capsule for curing hepatitis B - Google Patents

Yigan medical capsule for curing hepatitis B Download PDF

Info

Publication number
CN1144117A
CN1144117A CN 95113730 CN95113730A CN1144117A CN 1144117 A CN1144117 A CN 1144117A CN 95113730 CN95113730 CN 95113730 CN 95113730 A CN95113730 A CN 95113730A CN 1144117 A CN1144117 A CN 1144117A
Authority
CN
China
Prior art keywords
parts
radix
rhizoma
yigan
hepatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 95113730
Other languages
Chinese (zh)
Inventor
皇甫少剑
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 95113730 priority Critical patent/CN1144117A/en
Publication of CN1144117A publication Critical patent/CN1144117A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a Chinese medicine capsule specially for curing hepatitis B due to liver depression and spleen vacuity. Said invented Yiganyao Capsule is composed of the Chinese medicinal materials of Chinese angelica root, corydalis tuber, curcuma tuber, sparganium root, Lushou tea, ovate atractylodes root, notoginseng and Taibai tea. Its effective rate is 90%.

Description

Yigan medical capsule for curing hepatitis B
The present invention relates to a kind of Yigan medical capsule for curing hepatitis B that is exclusively used in the treatment hepatitis B.
Hepatitis B is higher at the sickness rate of China, and nearly 100,000,000 people are carriers of hepatitis B virus.Existing disease patient has 20,000,000 approximately, is seriously threatening people's livings body health, and it is more to treat the medicine of hepatitis B at present, mostly is Western medicine, and its curative effect is low, the expense height, and treatment cycle is long, and easily locates to recur.The treatment by Chinese herbs hepatitis B also had report, but its most just single-prescriptions, and its symptom of hepatitis B is in complicated clinical manifestation, and adopted a side singly to control, and its curative effect is very little.
The objective of the invention is the clinical manifestation at hepatitis B, suit the remedy to the case, work out serial YIGANKANG JIAONANG, use this capsule to be equipped with preparation, it is remarkable to have controlling symptoms, the negative conversion rate mystery, and short treating period, instant effect is difficult for the characteristics that recur.
Yigan medical capsule for curing hepatitis B provided by the invention is exclusively used in treatment because the hepatitis B that stagnation of liver-QI with deficiency of the spleen disease causes.
The object of the present invention is achieved like this, it is by Chinese medicine angelica, Radix Bupleuri, the Radix Paeoniae Alba, Radix Curcumae, rhizoma sparganic, Rhizoma Corydalis, HERBA PYROLAE, Rhizoma Smilacis Glabrae, the Rhizoma Atractylodis Macrocephalae, Radix Notoginseng, Radix Salviae Miltiorrhizae, too logical, the Bullus Notholirionis Bulbuliferi of Ramulus et Folium Mussaendae Pubescentis, Cladonia alpestris (L.) Rabenh., big blood, Radix Ginseng, the Radix Astragali etc. are formed, and it is by weight ratio:
20 parts of 10 portions of Radix Paeoniae Albas of 20 parts of Radix Bupleuri of Radix Angelicae Sinensis
15 parts of 10 parts of Rhizoma Corydalis of 10 parts of rhizoma sparganic of Radix Curcumae
15 parts of 20 parts of Rhizoma Atractylodis Macrocephalaes of 10 portions of Rhizoma Smilacis Glabraes of HERBA PYROLAE
20 parts of 6 parts of Radix Salviae Miltiorrhizaes of Radix Notoginseng are 10 parts of Ramulus et Folium Mussaendae Pubescentis too
10 parts of the logical 10 parts of Bullus Notholirionis Bulbuliferi of 10 parts of big blood of Cladonia alpestris (L.) Rabenh.
10 parts of 6 parts of Radixs Astragali of Radix Ginseng
Optimum implementation of the present invention:
Radix Angelicae Sinensis 20g Radix Bupleuri 10g Radix Paeoniae Alba 20g
Radix Curcumae 10g rhizoma sparganic 10g Rhizoma Corydalis 15g
HERBA PYROLAE 10g Rhizoma Smilacis Glabrae 20g Rhizoma Atractylodis Macrocephalae 15g
Radix Notoginseng 6g Radix Salviae Miltiorrhizae 20g is Ramulus et Folium Mussaendae Pubescentis 10g too
The big blood of Cladonia alpestris (L.) Rabenh. 10g leads to 10g Bullus Notholirionis Bulbuliferi 10g
Radix Ginseng 6g Radix Astragali 10g
By its prescription and weight proportion preparation, through concocting processing, pulverizing incapsulates shell and gets final product with said medicine.
The present invention is directed to the clinical manifestation of hepatitis B, work out serial YIGANKANG JIAONANG, be respectively applied for the liver damp-heat syndrome, the stagnation of liver-QI splenic disorder, hepatic and renal YIN deficiency disease and qi depression to blood stasis disease have depressed liver-energy dispersing and QI regulating, nourishing the kidney and liver, heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling through clinical observation, uses YIGANKANG JIAONANG to be equipped with preparation series, its control disease is remarkable, negative conversion rate mystery, short treating period, instant effect, the cure rate height is difficult for recurrence, its effective percentage reaches 90%, and be 80 days the course of treatment the shortest, and the longest is 160 days.
YIGANKANG JIAONANG provided by the invention is equipped with preparation, is exclusively used in the hepatitis B that treatment stagnation of liver-QI with deficiency of the spleen disease causes.

Claims (3)

1. Yigan medical capsule for curing hepatitis B that is exclusively used in the treatment hepatitis B is characterized in that it is by Radix Angelicae Sinensis, Radix Bupleuri, the Radix Paeoniae Alba, Radix Curcumae, rhizoma sparganic, Rhizoma Corydalis, HERBA PYROLAE, Rhizoma Smilacis Glabrae, the Rhizoma Atractylodis Macrocephalae, Radix Notoginseng, Radix Salviae Miltiorrhizae, too logical, the Bullus Notholirionis Bulbuliferi of Ramulus et Folium Mussaendae Pubescentis, Cladonia alpestris (L.) Rabenh., big blood, Radix Ginseng, the Radix Astragali etc. are formed.
2. Yigan medical capsule for curing hepatitis B as claimed in claim 1 is characterized in that above-mentioned prescription is by weight ratio:
20 parts of 10 portions of Radix Paeoniae Albas of 20 parts of Radix Bupleuri of Radix Angelicae Sinensis
15 parts of 10 parts of Rhizoma Corydalis of 10 parts of rhizoma sparganic of Radix Curcumae
15 parts of 20 parts of Rhizoma Atractylodis Macrocephalaes of 10 portions of Rhizoma Smilacis Glabraes of HERBA PYROLAE
20 parts of 6 parts of Radix Salviae Miltiorrhizaes of Radix Notoginseng are 10 parts of Ramulus et Folium Mussaendae Pubescentis too
10 parts of the logical 10 parts of Bullus Notholirionis Bulbuliferi of 10 parts of big blood of Cladonia alpestris (L.) Rabenh.
10 parts of 6 parts of Radixs Astragali of Radix Ginseng
3. as claim 1,2 described Yigan medical capsule for curing hepatitis B, it is characterized in that with said medicine through concocting, processing after the pulverizing, incapsulates shell and gets final product.
CN 95113730 1995-08-29 1995-08-29 Yigan medical capsule for curing hepatitis B Pending CN1144117A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 95113730 CN1144117A (en) 1995-08-29 1995-08-29 Yigan medical capsule for curing hepatitis B

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 95113730 CN1144117A (en) 1995-08-29 1995-08-29 Yigan medical capsule for curing hepatitis B

Publications (1)

Publication Number Publication Date
CN1144117A true CN1144117A (en) 1997-03-05

Family

ID=5080050

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 95113730 Pending CN1144117A (en) 1995-08-29 1995-08-29 Yigan medical capsule for curing hepatitis B

Country Status (1)

Country Link
CN (1) CN1144117A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106729347A (en) * 2015-11-19 2017-05-31 哈尔滨圣吉药业股份有限公司 A kind of stellate cladonia fruticose thallus soothing the liver menstruation regulating electuary and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106729347A (en) * 2015-11-19 2017-05-31 哈尔滨圣吉药业股份有限公司 A kind of stellate cladonia fruticose thallus soothing the liver menstruation regulating electuary and preparation method thereof

Similar Documents

Publication Publication Date Title
CN1124153C (en) Medicinal composition for restoring cardiac collaterals and its application
CN100356972C (en) Chinese medicine for treating amblyopia and myopia
CN102188560A (en) Traditional Chinese medicine for treating hyperlipidemia
CN1062157C (en) Hepatitis B curing toxin-dissipating pill
CN101028481A (en) Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion
CN1245707A (en) Chinese medicine for curing AIDS and carcinomatosis
CN101190323A (en) Orally-taken traditional Chinese medicine soup acquired immuno-deficiency syndrome
CN1112201C (en) Chinese medicine for curing hepatitis B and cirrhosis ascites
CN1103223C (en) Chinese medicine for treating cholecystitis
CN1136444A (en) Medicine for curing coronary heart disease
CN1145240A (en) Medicinal compsn. for prevention of Aids virus and cancer
CN1052413C (en) Yinhuang Ganfu powder for curing hepatitis
CN1159037C (en) Medicine for treating apoplexy
CN102100873B (en) Chinese patent medicine for treating heart cerebrovascular diseases and preparation method thereof
CN1186687A (en) Cancer preventing curing medicine series and its preparation
CN1218706C (en) Hepatitis B treaitng pill
CN1228063C (en) Medicine for treating liver disease
CN101862402A (en) Chinese medicament for treating liver diseases
CN1057230C (en) Traditional Chinese medicine capsule for treating thrombophlebitis
CN102813733A (en) Herb tea capable of resisting cancer, preventing diabetes mellitus and enhancing immunity
CN1332707C (en) Formula of Chinese herbal medicine decoction distinguished from males and females and combined with Western medicine for curing hepatitis B
CN1240415C (en) Tablets against allergic purpura
CN1144117A (en) Yigan medical capsule for curing hepatitis B
CN1263479C (en) Chinese traditional medicine for treating cardiopathy
CN101732423A (en) Chinese medicinal pills for treating hepatosplenomegaly

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication